Insiders · ZIVO

Mark E Strome

10% owner at Zivo Bioscience, Inc. (ZIVO)

Mark E Strome has filed 15 insider reports with the SEC since May 2023, as 10% owner at Zivo Bioscience, Inc. (ZIVO), director at HeartBeam, Inc. (BEAT) and insider at Arena Group Holdings, Inc. (PAAI). In the last 12 months Mark E Strome bought $995K and sold $895K of stock on the open market. In the latest filing, on April 24, 2026, Mark E Strome bought 100,000 shares of Zivo Bioscience, Inc. (ZIVO) for $200K at an average of $2.00.

Filings
15
Companies
3
Bought on market
$3.21M
Sold on market
$1.27M

Companies where Mark E Strome is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Zivo Bioscience, Inc. logo
ZIVO
Zivo Bioscience, Inc.
10% owner$2.61M$9.16Apr 24, 2026
HeartBeam, Inc. logo
BEAT
HeartBeam, Inc.
Directorsince May 202357,146$600K$895K$0.80$0.3089-61%Apr 17, 2026
Arena Group Holdings, Inc. logo
PAAI
Arena Group Holdings, Inc.
Insider$372K$0.46Jan 24, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Mark E Strome with

Other insiders at the same companies

Questions about Mark E Strome

What is Mark E Strome's role at Zivo Bioscience, Inc.?
Mark E Strome reports to the SEC as 10% owner at Zivo Bioscience, Inc. (ZIVO), according to the latest filing on April 24, 2026. Mark E Strome has also filed as director at HeartBeam, Inc. (BEAT) and insider at Arena Group Holdings, Inc. (PAAI).
How many shares does Mark E Strome own?
After the latest filing that states it, Mark E Strome directly owned 57,146 shares of HeartBeam, Inc. (BEAT). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Mark E Strome bought or sold stock recently?
The most recent open-market purchase was on April 17, 2026: bought 100,000 shares of Zivo Bioscience, Inc. (ZIVO) for $200K at an average of $2.00. The most recent open-market sale was on December 17, 2025: sold 250,000 shares of HeartBeam, Inc. (BEAT) for $895K at an average of $3.58.
How do I get alerts when Mark E Strome files?
Follow Mark E Strome on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Mark E Strome (SEC CIK 0000919484). Totals count each trade once, skipping amendments whose original is on file, from May 15, 2023 on. View on SEC EDGAR · Get this as JSON